MO665: 2 Icodextrin (2-ICO) Dwells in Peritoneal Dialysis (PD) Patients: One Center Experience
| Autor: | Elizabeth Viera Ramírez, R. Haridian Sosa Barrios, Víctor Burguera Vion, Irene Martin, Cristina Campillo Trapero, Milagros Fernandez Lucas, Rivera Maite |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Nephrology Dialysis Transplantation. 37 |
| ISSN: | 1460-2385 0931-0509 |
| Popis: | BACKGROUND AND AIMS Icodextrin is a soluble glucose polymer used widely as an alternative osmotic agent to glucose-only solutions in PD patients. It provides effective net peritoneal ultrafiltration (UF) and nowadays it is only licensed for once-daily dwells. However, in selected patients it has been described its use in two daily dwells (2-ICO). Our aim was to revise our center experience with icodextrin when prescribed as 2-ICO. METHOD We retrospectively analysed all patients with a 2-ICO dwell prescription in our PD unit from January 2018 until June 2021. Clinical data, indication for prescription and outcomes were collected. RESULTS CONCLUSION In selected patients, 2-ICO dwells daily may have a clinical benefit, improving UF significantly and allowing better management of fluid overload and UF failure without relevant adverse events. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|